Study Contributors

COVIDRIVE’s Study Contributors network consists of 25 study sites from 13 different European countries: Austria, Belgium, Croatia, Finland, France, Germany, Iceland, Italy, Netherlands, Poland, Romania, Spain and the United Kingdom. Our network includes more than 50 hospitals, 5 primary care networks and a nation-wide register in Finland.
COVIDRIVE Study Contributors network (as of 30th of June 2022).

COVIDRIVE is open to include new study sites in its European network. For more information on how to join COVIDRIVE, please see section “Participate

  • Centro Interuniversitario per la Ricerca sull’Influenza e le altre Infezioni Trasmissibili (CIRI-IT, Italy)
  • COVIREIVAC hospital network, France
  • Finnish Institute for Health and Welfare (THL, Finland)
  • Fisabio VAHNSI hospital network (Spain)
  • Hospital Universitario de Salamanca (Spain)
  • Hospital Universitario Germans Trias i Pujol (Spain)
  • Hospital Universitario La Paz (Spain)
  • Grand Hôpital de Charleroi (Belgium)
  • University Hospital Antwerp (UZA, Belgium)
  • German Centre for Infection Research (DZIF hospital network, Germany)
  • GZIM GP network (Germany)
  • Forum Impfen GP network (Germany)
  • Uniklinikum Freiburg (Germany)
  • Hospital Universitario Vall d’Hebron and Hospital Universitario Josep Trueta (Spain)
  • Iceland Directorate of Health (Iceland)
  • Imperial College London Health Partners (United Kingdom)
  • Klinik Favoriten Hospital (Austria)
  • LOGEX (Netherlands)
  • National Institute for Infectious Diseases, “Prof. Dr. Matei Bals” (Romania)
  • National Institute of Public Health (Poland)
  • North West E-health (United Kingdom)
  • BREATHE consortium (United Kingdom) 
  • University Hospital Ghent (Belgium)
  • CHU Saint Pierre Hospital Brussels (Belgium)
  • Hospital Fran Mihaljevic Zagreb (Croatia)